Pulmonary Vascular Disease

Explore clinical trials studying Pulmonary Vascular Disease. Study availability and eligibility vary by location and protocol.

17 public trials 6 recruiting studies

Refine in advanced search Browse all conditions

Pulmonary Vascular Disease trial results

Not yet recruiting

Sleep-Assessment in Patients Between High Altitude HA vs. Sea Level LA in Patients With Pulmonary Arterial Hypertension PAH

NCT07801963

Conditions: Altitude Sickness, Apnea, Cardiovascular Diseases, +23 more
Locations: University Hospital of Zurich Zurich, Switzerland

View Trial Details

Not yet recruiting

Assessment of Heart Rate Variability HRV During Descent DE From 2850m to Sea Level and During Re-ascent A From Sea Level to 2850m in Patients With Pulmonary Arterial Hypertension PAH

NCT07801859

Conditions: Altitude Sickness, Cardiovascular Diseases, ECG Abnormalities, +12 more
Locations: University Hospital of Zurich Zurich, Switzerland

View Trial Details

Not yet recruiting

Assessment of Six-minute Walking Distance Between Sea Level LA vs. High Altitude HA After Re-ascent in Patients With Pulmonary Arterial Hypertension PAH

NCT07797166

Conditions: Altitude Sickness, High Altitude, High Altitude Effects, +13 more
Locations: University Hospital of Zurich Zurich, Switzerland

View Trial Details

Completed

Assessing Response to Inhaled Prostacyclin With Hyperpolarized Xe MRI

NCT03367312

Conditions: Pulmonary Vascular Disease
Locations: Duke University Medical Center Durham, North Carolina, United States

View Trial Details

Completed

Non-Invasive Diagnosis of Pulmonary Vascular Disease Using Inhaled 129Xe Magnetic Resonance Imaging

NCT03078192

Conditions: Lung Diseases, Pulmonary Vascular Disease, Respiratory Tract Diseases
Locations: Duke University Medical Center Durham, North Carolina, United States

View Trial Details

Completed

Evaluation of Dynamic Pulmonary Vascular Resistance in Patients With Closed Ventricular Septal Defect

NCT02648984

Conditions: Pulmonary Vascular Disease
Locations: University Hospitals Leuven Leuven, Belgium

View Trial Details

Completed

EZ-2053 in the Prophylaxis of Acute Pulmonary Allograft Rejection

NCT00105183

Conditions: Bronchial Diseases, Bronchiectasis, Chronic Obstructive Pulmonary, +12 more
Locations: Cedars-Sinai Medical Center Los Angeles, California, United States

University of California, San Francisco San Francisco, California, United States

Stanford University Stanford, California, United States

Mayo Clinic Jacksonville, Florida, United States

View all 19 locations

View Trial Details

Pulmonary Vascular Disease

Pulmonary Vascular Disease trial results

Sleep-Assessment in Patients Between High Altitude HA vs. Sea Level LA in Patients With Pulmonary Arterial Hypertension PAH

Assessment of Heart Rate Variability HRV During Descent DE From 2850m to Sea Level and During Re-ascent A From Sea Level to 2850m in Patients With Pulmonary Arterial Hypertension PAH

Assessment of Six-minute Walking Distance Between Sea Level LA vs. High Altitude HA After Re-ascent in Patients With Pulmonary Arterial Hypertension PAH

Assessing Response to Inhaled Prostacyclin With Hyperpolarized Xe MRI

Non-Invasive Diagnosis of Pulmonary Vascular Disease Using Inhaled 129Xe Magnetic Resonance Imaging

Evaluation of Dynamic Pulmonary Vascular Resistance in Patients With Closed Ventricular Septal Defect

EZ-2053 in the Prophylaxis of Acute Pulmonary Allograft Rejection

Related conditions